Cryo-Cell International Inc (CCEL) stock
CCELNYSEServices-Misc Health & Allied Services, NECFiscal year ends November 30
$4.17−0.46 (-9.94%)
Close on Nov 18, 2026Market cap $33.62MP/E –Yield –
Cryo-Cell International shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Cryo-Cell International's shares outstanding was 8M at Aug 31, 2026. For fiscal 2025 it was 8M, down 1.8% from the year before. Over ten years it grew -1.9% a year on average. The highest annual figure on record is 12M in fiscal 2010.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Nov 30, 2025 | 8M | -1.8% |
| FY2024 | Nov 30, 2024 | 8M | -1.5% |
| FY2023 | Nov 30, 2023 | 8M | -1.7% |
| FY2022 | Nov 30, 2022 | 8M | +1.5% |
| FY2021 | Nov 30, 2021 | 8M | +2.7% |
| FY2020 | Nov 30, 2020 | 8M | -3.2% |
| FY2019 | Nov 30, 2019 | 8M | +12.7% |
| FY2018 | Nov 30, 2018 | 7M | -2.5% |
| FY2017 | Nov 30, 2017 | 8M | -5.7% |
| FY2016 | Nov 30, 2016 | 8M | -17.2% |
| FY2015 | Nov 30, 2015 | 10M | -6.1% |
| FY2014 | Nov 30, 2014 | 10M | -5.0% |
| FY2013 | Nov 30, 2013 | 11M | -3.0% |
| FY2012 | Nov 30, 2012 | 11M | -3.9% |
| FY2011 | Nov 30, 2011 | 12M | -0.4% |
| FY2010 | Nov 30, 2010 | 12M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
Periods
| Period | Period end | Value | Change |
|---|---|---|---|
| Q3 FY2026CQ3 2026 | Aug 31, 2026 | 8M | -0.1% |
| Q2 FY2026CQ2 2026 | May 31, 2026 | 8M | -0.9% |
| Q1 FY2026CQ1 2026 | Feb 28, 2026 | 8M | -1.8% |
| Q4 FY2025CQ4 2025 | Nov 30, 2025 | 8M | -2.8% |
| Q3 FY2025CQ3 2025 | Aug 31, 2025 | 8M | -1.2% |
| Q2 FY2025CQ2 2025 | May 31, 2025 | 8M | -1.3% |
| Q1 FY2025CQ1 2025 | Feb 28, 2025 | 8M | -1.5% |
| Q4 FY2024CQ4 2024 | Nov 30, 2024 | 8M | -1.4% |
| Q3 FY2024CQ3 2024 | Aug 31, 2024 | 8M | -2.0% |
| Q2 FY2024CQ2 2024 | May 31, 2024 | 8M | -1.2% |
| Q1 FY2024CQ1 2024 | Feb 29, 2024 | 8M | -1.8% |
| Q4 FY2023CQ4 2023 | Nov 30, 2023 | 8M | -3.2% |
| Q3 FY2023CQ3 2023 | Aug 31, 2023 | 8M | -0.7% |
| Q2 FY2023CQ2 2023 | May 31, 2023 | 8M | -2.6% |
| Q1 FY2023CQ1 2023 | Feb 28, 2023 | 8M | -3.1% |
| Q4 FY2022CQ4 2022 | Nov 30, 2022 | 9M | -3.2% |
| Q3 FY2022CQ3 2022 | Aug 31, 2022 | 8M | -3.3% |
| Q2 FY2022CQ2 2022 | May 31, 2022 | 9M | +3.4% |
| Q1 FY2022CQ1 2022 | Feb 28, 2022 | 9M | +6.7% |
| Q4 FY2021CQ4 2021 | Nov 30, 2021 | 9M | +7.9% |
| Q3 FY2021CQ3 2021 | Aug 31, 2021 | 9M | +6.3% |
| Q2 FY2021CQ2 2021 | May 31, 2021 | 8M | +2.0% |
| Q1 FY2021CQ1 2021 | Feb 28, 2021 | 8M | +0.9% |
| Q4 FY2020CQ4 2020 | Nov 30, 2020 | 8M | -2.5% |
| Q3 FY2020CQ3 2020 | Aug 31, 2020 | 8M | -3.1% |
| Q2 FY2020CQ2 2020 | May 31, 2020 | 8M | -3.7% |
| Q1 FY2020CQ1 2020 | Feb 29, 2020 | 8M | -3.5% |
| Q4 FY2019CQ4 2019 | Nov 30, 2019 | 8M | +7.2% |
| Q3 FY2019CQ3 2019 | Aug 31, 2019 | 8M | +0.8% |
| Q2 FY2019CQ2 2019 | May 31, 2019 | 8M | +6.4% |
| Q1 FY2019CQ1 2019 | Feb 28, 2019 | 8M | +18.6% |
| Q4 FY2018CQ4 2018 | Nov 30, 2018 | 8M | +2.3% |
| Q3 FY2018CQ3 2018 | Aug 31, 2018 | 8M | +7.5% |
| Q2 FY2018CQ2 2018 | May 31, 2018 | 8M | +2.5% |
| Q1 FY2018CQ1 2018 | Feb 28, 2018 | 7M | -4.5% |
| Q4 FY2017CQ4 2017 | Nov 30, 2017 | 8M | +11.9% |
| Q3 FY2017CQ3 2017 | Aug 31, 2017 | 8M | – |
| Q2 FY2017CQ2 2017 | May 31, 2017 | 8M | – |
| Q1 FY2017CQ1 2017 | Feb 28, 2017 | 7M | – |
| Q4 FY2016CQ4 2016 | Nov 30, 2016 | 7M | – |
See a number that looks wrong?